News / New publications

Research

We work together for a better translational approach, from basic to clinical science

  • Read more

Core facilities

Our advanced core facilities offer excellent opportunities

  • Read more

Recruitment

We welcome the best research talents from Norway and the rest of the world

  • Read more

Archives IEMR

  • Publications
  • News archive
  • Visual profile

About IEMR

  • About
  • Funding
  • Collaborations
  • Staff

Contact IEMR

  • Contact
  • Group leaders
  • Leadership
  • Safety representative (VO)

MicroRNAs Diagnostic Performance in Heart Failure: a Systematic Review and Meta-Analysis

Reza Parvan, Milad Hosseinpour, Yousef Moradi, Yvan Devaux, Alessandro Cataliotti, Gustavo J.J. da Silva

—

Heart Failure (HF) is the leading cause of death worldwide. Chronic HF (CHF) can be classified as HF with preserved ejection fraction (HFpEF), HF with mid-range ejection fraction (HFmrEF), and HF with reduced ejection fraction (HFrEF). Currently, there is an unmet need for a minimally invasive diagnostic tool to differentiate different forms of CHF. Studies suggest that circulating microRNAs (miRNAs) could be used as diagnostic and prognostic tools.

We aimed to investigate the diagnostic potential of circulating miRNAs for the detection of different CHF forms via a systematic review and meta-analysis approach. Using comprehensive search strategy we identified 45 relevant studies in different databases (MedLine, Scopus, Web of Science and Embase). After qualitative assessment, 29 studies out of 45 studies were used for quantitative assessment and allowed to identify miRNA panels able to detect HFrEF (AUC: 0.86) and HFpEF (AUC: 0.79). A panel of eight miRNAs (hsa-miR-18b-3p, hsa-miR-21-5p, hsa-miR-22-3p, hsa-miR-92b-3p, hsa-miR-129-5p, hsa-miR-320a-5p, hsa-miR-423-5p, and hsa-miR-675-5p) identified HFrEF patients with a sensitivity of 0.85 and specificity of 0.88. A panel of seven miRNAs (hsa-miR-19b-3p, hsa-miR-30c-5p, hsa-miR-206, hsa-miR-221-3p, hsa-miR-328-5p, hsa-miR-375-3p, and hsa-miR-424-5p) identified HFpEF patients with a sensitivity of 0.82 and a specificity of 0.61. Due to the lack of data, we could not perform the analysis regarding HFmrEF.

Our study showed reasonable performance of miRNAs in the detection of HFrEF and HFpEF. Furthermore, our data suggest that the use of miRNAs can improve the diagnostic power of conventional biomarkers in different forms of CHF. However, for a complete evaluation of the potential role of miRNAs in the detection of CHF, larger population studies are still required.

Eur J Heart Fail. 2022 Sep 25

PMID: 36161443, DOI: 10.1002/ejhf.2700

Reza Parvan

Doctoral Research Fellow

  • View profile

Alessandro Cataliotti

Group Leader & Professor

  • View profile

Institute for Experimental Medical Research

Oslo University Hospital, Ullevål

PB 4956 Nydalen

NO-0424 Oslo

Norway

  • Research
  • Core facilities
  • Recruitment
  • Publications
  • News archive
  • Visual profile
  • About
  • Funding
  • Collaborations
  • Staff
  • Contact
  • Group leaders
  • Leadership
  • Safety representative (VO)